Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension

Journal of the American College of Cardiology

Volumn 31, Issue 2, 1998, Pages 374-382

  Houghton, Jan L ^a   Davison, Cathy A ^a   Kuhner, Patricia A ^a   Torossov, Mikhail T ^a   Strogatz, David S ^b   Carr, Albert A ^c  

^a Division of Cardiology   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c Circulatory Disease Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM;

EID: 0031976631     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00505-6     Document Type: Article

References (46)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
2. Bassenge E, Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis. 30:1988;349-380.
3. Vane R, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 323:1990;27-36.
4. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis of nitric oxide from L-arginine a pathway for the regulation of cell function and communication . Biochem Pharmacol. 38:1989;1709-1715.
5. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med. 314:1986;488-500.
6. Zeiher A, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans progressive endothelial dysfunction with different early stages of coronary atherosclerosis . Circulation. 83:1991;391-401.
7. White RM, Rivera CO, Davison CB. Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats. Hypertension. 27:1996;1245-1253.
8. Hwa JJ, Ghibaudi L, Williams P, Chatterjee M. Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed. Am J Physiol. 266:1994;H952-H958.
9. Brush J, Faxon D, Salmon S, Jacobs A, Ryan T. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol. 19:1992;809-815.
10. Treasure CB, Klein L, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 87:1993;86-93.
11. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:1990;22-27.
12. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
13. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Impaired endothelium-dependent vasodilation in patients with essential hypertension evidence that the abnormality is not at the muscarinic receptor level . J Am Coll Cardiol. 23:1994;1610-1616.
14. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 24:1994;1468-1474.
15. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO III. Impaired endothelium-dependent vasodilation in patients with essential hypertension evidence that nitric oxide abnormality is not localized to a single signal transduction pathway . Circulation. 91:1995;1732-1738.
16. Di Mario CD, Strikwerda S, Gil R, de Feyter PJ, de Jaegere P, Serruys PW. Response of conductance and resistance coronary vessels to scalar concentrations of acetylcholine assessment with quantitative angiography and intracoronary Doppler echography in 29 patients with coronary artery disease . Am Heart J. 127:1994;514-531.
17. Hodgson JM, Marshall JJ. Direct vasoconstriction and endothelium-dependent vasodilation mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries . Circulation. 79:1989;1043-1051.
18. Martin W, Furchgott RF, Villani GM, Jothianandan D. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther. 237:1986;529-538.
19. Dohi Y, Thiel MA, Buhler FR, Luscher TF. Activation of endothelial L-arginine pathway in resistance arteries effect of age and hypertension . Hypertension. 15:1990;170-179.
20. King CM, Webb RC. The endothelium partially obscures enhanced microvessel reactivity in DOCA hypertensive rats. Hypertension. 12:1988;420-427.
21. Houghton JL, Smith VE, Strogatz DS, Henches NL, Breisblatt WM, Carr AA. Effect of African American race and hypertensive left ventricular hypertrophy on coronary vascular reactivity and endothelial function. Hypertension. 29:1997;706-714.
22. Levy D, Savage D, Garrison R, Anderson D, Kannell W, Castelli W. Echocardiographic criteria for left ventricular hypertrophy the Framingham Heart Study . Am J Cardiol. 59:1987;956-960.
23. Troy BC, Pombo J, Rackley C. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 45:1972;602-611.
24. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man anatomic validation of the method . Circulation. 55:1977;613-618.
25. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 23:1994;833-843.
26. Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol. 105:1992;429-435.
27. Stoltz JF, Zannad F. Blood rheology in hypertension. J Hypertens. 10:(Suppl 5):1992;569-578.
28. Luscher T, Boulanger CM, Dohi Y, Zung Z. Endothelium-derived contracting factors. Hypertension. 19:1992;117-130.
29. Marcus ML, Chilian WM, Kanatsuka H, Dellsperger KC, Eastham CL, Lamping KG. Understanding the coronary circulation through studies at the microvascular level. Circulation. 82:1990;1-7.
30. Klassen GA, Armour JA, Garner JB. Coronary circulatory pressure gradients. Can J Physiol Pharmacol. 65:1987;520-531.
31. Marcus ML. The Coronary Circulation in Health and Disease. 1983;93-112 McGraw-Hill, New York.
32. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age related decline in women. J Am Coll Cardiol. 24:1994;471-476.
33. Treasure CB, Vita JA, Cox DA, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81:1990;772-779.
34. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans effects of age, atherosclerosis, hypercholesterolemia, and hypertension . J Clin Invest. 92:1993;652-662.
35. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 338:1991;1546-1550.
36. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin dependent diabetes mellitus. Circulation. 88:1993;2510-2516.
37. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL, Lopez AG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation constriction of epicardial and resistance vessels . J Am Coll Cardiol. 22:1993;642-647.
38. Herrington DM, Braden GA, Williams JK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 73:1994;951-952.
39. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497.
40. Cannan CR, Higano ST, Holmes JR, Garratt KN, Lerman A. Beyond the coronary angiogram further evaluation of the coronary vasculature and endothelial function . J Interven Cardiol. 9:1996;153-161.
41. Vita JA, Keaney JF Jr, Loscalzo J. Endothelial dysfunction in vascular disease. Loscalzo J, Creager MA, Dzau VJ. Vascular Medicine A Textbook of Vascular Biology and Diseases . 2nd ed. 1996;245-263 Little, Brown, Boston.
42. Uehata A, Matsuguchi T, Bittl JA, et al. Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter. Circulation. 88:(Pt. 1):1993;1724-1729.
43. Foley DP, Escaned J, Strauss BH, et al. Quantitative coronary angiography (QCA) in interventional cardiology clinical application of QCA measurements . Prog Cardiovasc Dis. 36:1994;363-384.
44. Popma JJ, Kuntz RE. The practical application of quantitative angiographic methods for investigating newer coronary interventions and balloon angioplasty. White CJ, Ramee SR. Interventional Cardiology New Techniques and Strategies for Diagnosis and Treatment . 1995;79-112 Marcel Dekker, New York.
45. Silver KH, Buczek JA, Esser PD, Nichols AB. Quantitative analysis of coronary arteriograms by microprocessor cinevideodensitometry. Cathet Cardiovasc Diagn. 13:1987;291-300.
46. Quyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation. J Clin Invest. 95:1995;1747-1755.